HEADLINES: • Magyar Telekom: regulatory risk outweighs the growth story (downgraded to HOLD) • DataWalk: actual 4Q24 figures in line with the prelims; strong hikes in sales funnel and value of acquired contracts in 1Q25 POSITIVE • LPP: key takeaways from 4Q24 and the strategy update presentation POSITIVE • Text: key takeaways from the 4Q24-25 preliminary earnings call NEUTRAL • Colt CZ Group SE: management's initial comment on US tariffs NEGATIVE • European oil and gas monthly: March 2025 – refi...
Average Brent crude oil prices were down by USD 3.5/bbl in March vs. the previous month, and OPEC+ promised to mitigate increased supply with compensatory cuts from countries above quota. The WOOD benchmark was down USD 4.0/bbl, to USD 8.0/bbl, the lowest margin since September 2024. Only fuel oil cracks improved, while crude differentials worsened. Petrochemicals continue to disappoint.
HEADLINES: • LPP: mediocre 4Q24 – EBIT 4-5% below expectations, but decent start to the year; FY25E guidance broadly maintained, and FY26-27E guidance of stable margins, despite major sales growth acceleration POSITIVE • EEMEA macro: US reciprocal tariff effects • Trade Estates: strong 2024 results POSITIVE • Motor Oil Hellas: 4Q24 results – CCS EBITDA in line with the consensus, but net income weak NEUTRAL • Eurocash: 4Q24 in line with the prelims NEUTRAL • Text: 4Q24-25 (calendar 1Q25) prelimi...
EME Equity Market – March 2025 Türkiye hammered, once again. The MSCI EM Europe Index advanced 0.5% in EUR terms and 4.5% mom in USD terms in March. The Czech PX Index was the best performer (+7.0% mom in EUR terms), followed by the Greek ASE (+4.8% mom), Polish WIG (+3.7% mom) and Hungarian BUX(+1.3% mom) indices (all in EUR terms). There was a muted performance from the Romanian BET Index (-0.1% mom in EUR terms). The Turkish ISE30 finished in the red again, declining 9.5% mom in EUR terms.
HEADLINES: • Athens Exchange Group: bottom-line miss in 4Q24, on higher costs, but proposed DPS in line with expectations NEUTRAL • AROBS Transilvania Software: publishes its 2025 budget POSITIVE • MedLife: publishes its 2025 budget NEGATIVE • CCC: new financing agreement, extending factoring line POSITIVE • DataWalk: sale to Coöperatieve Rabobank; total contract value reaches PLN 66.1m POSITIVE • Orlen: 2024 consolidated results to be affected by one-offs NEUTRAL • Poland macro: preliminary Mar...
HEADLINES: • Polish banks: pricing and believing (PKO BP, Bank Pekao, Santander BP, mBank, ING BSK, Bank Millennium, Alior Bank, Bank Handlowy) • Asseco Poland: 4Q24 review – net profit up 9% yoy, 9% above the consensus POSITIVE • InPost: 4Q24 in line with expectations; FY25E EBITDA growth guidance in the mid-20%s, but a slow start to the year POSITIVE • Kety: solid full 4Q24 results, with EBITDA 12% above preliminaries POSITIVE • Halyk Bank: 4Q24 review and 2025E guidance highlights • Titan Cem...
The Polish banks have rallied 35% ytd, but the median total return for the LTM has arrived at 18%+ for the Polish banks under our coverage. We feel that the market is currently in a similar place to exactly a year ago. The banks have performed well since the end of last year, but valuations remain attractive, with our 2025-26E median P/Es of 9.0-8.2x, at discounts to the long-term valuation levels and with solid single-digit dividend yields in 1H25E. Our upgraded forecasts imply a 10% median EPS...
HEADLINES: • Orange Polska: strategy focused on growth (stays BUY) • Ignitis Group: making headway (BUY - transfer of coverage) • PZU: 4Q24 well ahead of expectations, holding structure to be created within PZU group POSITIVE • Grupa Pracuj: 4Q24 results – EBITDA up 9% yoy, 9% above our forecast and 1% above the consensus POSITIVE • Colt CZ Group SE: FY24 results review NEUTRAL • Public Power Corporation: 4Q24 earnings, and preview of a potential mega data centre NEUTRAL • Lamda Development: 4Q2...
HEADLINES: • Polish banks: Financial Stability Committee mentions sanction of free credit risk for consumer loans portfolio NEGATIVE • DataWalk: preliminary 4Q24 results – sales up 19% yoy, to PLN 9.09m POSITIVE • Türkiye macro: putting the CBRT’s emergency rate hike into context • EME Macro/Strategy: macro all-in-one (17-23 March) • GTC: solvency of controlling investor in question, after State Audit Office of Hungary's report • Banca Transilvania: dividend proposal from the 2024 profits NEUTRA...
HEADLINES: • Benefit Systems: pumping iron (stays BUY) • Jeronimo Martins: small beat in 4Q24, Biedronka margin erosion slows down; tough market environment continues in 2025 POSITIVE • OPAP: the beat goes on, in 4Q24 POSITIVE • Tauron: preliminary 4Q24 EBITDA 45% above our estimate, on strong Generation and Distribution, and lower loss in Supply POSITIVE • Türkiye macro: assessment of recent political events • Allegro vs. InPost: our take on the companies' two calls • cyber_Folks / Shoper: key ...
HEADLINES: • Pepco Group: structurally challenged (downgraded to HOLD) • Air Astana Group: 4Q24 – good, at first glance; dividend surprises positively • CEZ: takeaways from the 4Q24 earnings call NEGATIVE • Allegro: key takeaways from the 4Q24 call POSITIVE • Shoper: takeaways from the post-4Q24 prelims management call NEUTRAL • Polish banks: receive maximum dividend payout ratio letters from the PFSA – no surprises NEUTRAL • Mo-BRUK: unfavourable ruling results in closure of Wałbrzych branch (2...
HEADLINES: • BIM: strong operating results in 4Q24 POSITIVE • Bank Handlowy: 4Q24 results do not bring much new to the table NEUTRAL • Sok Marketler Ticaret: recovery in operating results masked by bottom-line loss in 4Q24 NEUTRAL • GEVORKYAN: 4Q24 results – lower than expected, due to one-off expenses NEUTRAL • Benefit Systems: key takeaways from the call on the MAC Group acquisition in Türkiye POSITIVE • Grupa Pracuj: PLN 28.6m revaluation of Beamery to harm 2024 results NEGATIVE • Budimex: an...
A director at Med Life SA sold 1,000,000 shares at 5.800RON and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Average Brent crude oil prices were down USD 3.4/bbl in February, vs. the previous month, and OPEC+ promised to increase supply. The WOOD benchmark margin was up USD 2.4/bbl to USD 12.0/bbl, its widest level since April 2024. All product cracks improved, but this may be just maintenance. Petrochemicals continue to disappoint.
HEADLINES: • MedLife: and let the operational gearing begin (upgraded to BUY) • Enea: preliminary 4Q24 results broadly in line with expectations NEUTRAL • Elm: 4Q24 conference call takeaways • 4iG: 4Q24 earnings call takeaways NEUTRAL • Türkiye macro: February inflation performs better than the CBT’s projections • OMV: agrees on Borealis, Borouge and Nova chemicals deal with ADNOC POSITIVE • InPost: extension of available financing to PLN 4.2bn, from PLN 2.8bn POSITIVE • Wizz Air: February capac...
Following the 4Q24 earnings release, we have updated our 12M price target for MedLife to RON 7.1/share and upgraded our rating from Hold to BUY, with upside of c.20%. Last year was the inflection point for the EBITDA, growing 36% yoy. Below the EBITDA, these gains were largely offset by higher depreciation, interest expense and taxes; only c.20% of the upside made it to the bottom line. We expect that to reverse this year, on: 1) more modest growth in depreciation and taxes; and 2) a c.20% drop ...
EME Equity Market – February 2025 Poland outperforms, again; Türkiye declines. The MSCI EM Europe Index advanced by 3.1% in EUR terms and 2.9% mom in USD terms in February. The Polish WIG20 was, once again, the best performer, adding 7.3% mom in February; followed by the Czech PX Index (+6.1% mom); while Greece (+3.8% mom), Hungary (+3.5% mom) and Romania (+3.0% mom) all reported rather similar performances. The Turkish ISE30 was the worst performer, declining 4.5% mom.
HEADLINES: • EME Macro/Strategy: macro all-in-one (24 February-2 March) • National Bank of Greece: 4Q24 results and 2025-27E guidance highlights NEUTRAL • Patria Bank: 4Q24 bottom-line miss due mostly to lower non-interest income NEGATIVE • 4iG: 4Q24 results review – 22% yoy reported EBITDA increase, in line with our estimate; bottom-line miss, on D&A hike NEUTRAL • Sphera Group: 4Q24 soft, as expected; webcast takeaways NEGATIVE • Duna House: 4Q24 – FY results in line, lower DPS, but possible u...
In line with our expectations, Sphera has reported a relatively soft set of results for 4Q24, due to: i) the tough base of the very strong 4Q23; ii) continuing wage pressure; and iii) higher taxation. While the sales growth decelerated to 3% yoy (in line with our expectations), labour costs expanded by 10% yoy, driving EBITDA erosion of 10% yoy, to RON 48m, 2% above our forecast. On the bottom line, Sphera delivered a 30% yoy drop, 2% above our expectations.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.